NEW YORK (
) hit a new 52-week high Friday as it traded at $25.50 compared with its previous 52-Week high of $25.49. Amsurg is changing hands at $25.48 with 12,080 shares traded as of 11:11 a.m. ET. Average volume has been 147,300 shares over the past 30 days.
Amsurg has a market cap of $788.3 million and is part of the
industry. Shares are up 18.7% year to date as of the close of trading on Thursday.
AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. The company has a P/E ratio of 14.9, below the average health services industry P/E ratio of 15.5 and below the S&P 500 P/E ratio of 16.
- Practice your AMSG trading strategies and win cash in our stock game.
TheStreet Ratings rates Amsurg as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our